Somewhat Positive Media Coverage Somewhat Unlikely to Impact USANA Health Sciences (USNA) Stock Price

Press coverage about USANA Health Sciences (NYSE:USNA) has trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. USANA Health Sciences earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 43.8694563856009 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

These are some of the media stories that may have effected Accern Sentiment Analysis’s analysis:

Shares of USANA Health Sciences (NYSE:USNA) opened at $74.30 on Friday. USANA Health Sciences has a 1 year low of $52.55 and a 1 year high of $76.15. The firm has a market cap of $1,786.24, a PE ratio of 20.47 and a beta of 1.06.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.02 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.11. The business had revenue of $261.77 million during the quarter, compared to the consensus estimate of $259.52 million. USANA Health Sciences had a net margin of 8.79% and a return on equity of 26.38%. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.40 EPS. sell-side analysts predict that USANA Health Sciences will post 3.7 earnings per share for the current year.

A number of equities research analysts recently weighed in on the stock. Pivotal Research boosted their price objective on shares of USANA Health Sciences from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, October 25th. BidaskClub downgraded shares of USANA Health Sciences from a “hold” rating to a “sell” rating in a research report on Thursday, November 2nd.

In other USANA Health Sciences news, major shareholder Global Ltd Gull sold 60,871 shares of the business’s stock in a transaction dated Thursday, October 26th. The shares were sold at an average price of $67.39, for a total transaction of $4,102,096.69. Following the completion of the transaction, the insider now directly owns 12,089,267 shares of the company’s stock, valued at approximately $814,695,703.13. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Myron W. Wentz sold 164,916 shares of the business’s stock in a transaction dated Tuesday, November 21st. The shares were sold at an average price of $66.40, for a total transaction of $10,950,422.40. The disclosure for this sale can be found here. Insiders have sold a total of 623,752 shares of company stock valued at $41,411,372 over the last three months. 53.20% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION WARNING: This news story was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with's FREE daily email newsletter.

Leave a Reply